In a preclinical model of acute pericarditis, cannabidiol was found to significantly reduce pericardial effusion and thickening. The Food and Drug Administration (FDA) has granted Orphan Drug ...
Sequence variants that protect against pericarditis have been discovered at a genomic locus encoding interleukin-1 immune cytokines. A newly approved drug treatment for pericarditis inhibits these ...
Kiniksa Pharmaceuticals Ltd. Class A (($KNSA)) announced an update on their ongoing clinical study. Study Overview: Kiniksa Pharmaceuticals Ltd.
Myocarditis and pericarditis are conditions that involve heart inflammation. Myocarditis affects the heart muscle itself, while pericarditis impacts the pericardium — the layer of tissue that ...
LONDON, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases ...
(RTTNews) - Scilex Holding Co. (SCLX) announced that FDA has approved it request for the Orphan drug designation for colchicine for the treatment of pericarditis. Pericarditis is an inflammation of ...
Pericarditis chest pain may be worsened when you lie down. While acute cases resolve within a few weeks, the symptoms can still interfere with your ability to sleep. Pericarditis is a type of heart ...
Please provide your email address to receive an email when new articles are posted on . In patients with lupus, those taking prednisone or demonstrating active disease and a more recent initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback